insights_auto
Why is ARX down 4.72%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
AU$0.50
arrow_downward
-4.72%(-0.025) 1D
ኖቬም 9, 4:10:11 ከሰዓት ጂ ኤም ቲ+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
AU$0.53
High
AU$0.53
Low
AU$0.50
Mkt. cap
174.68 ሚ
Avg. vol.
298.96 ሺ
Volume
149.59 ሺ
P/E ratio
48.60
52-wk high
AU$0.78
52-wk low
AU$0.46
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
Open
AU$0.53
High
AU$0.53
Low
AU$0.50
Mkt. cap
174.68 ሚ
Avg. vol.
298.96 ሺ
Volume
149.59 ሺ
P/E ratio
48.60
52-wk high
AU$0.78
52-wk low
AU$0.46
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
News stories
From web sources and news partners
Benzinga
·
ከ11 ደቂቃዎች በፊት
History Suggests Last Week's Selloff Was a Buying Opportunity - State Street SPDR S&P 500 ETF Trust (ARCA
TradingView
·
ከ58 ደቂቃዎች በፊት
News by CNBC TV18 on TradingView, 2026-11-09 — cnbctv:d3dc38c2d094b:0
WTNH.com
·
ከ2 ሰዓቶች በፊት
Asian markets bounce back after a recovery for AI stocks on Wall Street
Yahoo Finance
·
ከ2 ሰዓቶች በፊት
Dow, S&P 500, Nasdaq Futures Rebound After Sharp AI Selloff Last Week: NVDA, AMD, VIR, SNDK In Focus
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd